Skip to main content
. 2020 Dec 15;12(1):1849998. doi: 10.1080/19490976.2020.1849998

Figure 4.

Figure 4.

Subdoligranulum variabile supplementation does not impact on lipid metabolism

Effect of Subdoligranulum variabile administration on (A) liver weight (g), (B) liver lipid content (%), (C) liver triglycerides (mmol/mg), (D) liver cholesterol, (mmol/mg) (E) plasma triglycerides (mg/dl) and (F) plasma cholesterol (mg/dl). Data are represented as means ± SEM. Data were analyzed using one-way ANOVA followed by a Tukey post hoc test. ‘*’ indicates a significant difference versus HFD (P < .05).